We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+4.76%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$13.4B
AUM Growth
+$1.43B
Cap. Flow
+$857M
Cap. Flow %
6.4%
Top 10 Hldgs %
14.37%
Holding
602
New
156
Increased
172
Reduced
106
Closed
146

Top Buys

Rank Stock Value
1
TXN icon
Texas Instruments
TXN
+$175M
2
LOW icon
Lowe's Companies
LOW
+$167M
3
AZO icon
AutoZone
AZO
+$127M
4
NTRS icon
Northern Trust
NTRS
+$127M
5
MRK icon
Merck
MRK
+$118M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$133M
2
RAI
Reynolds American Inc
RAI
+$126M
3
KEY icon
KeyCorp
KEY
+$113M
4
WMT icon
Walmart Inc
WMT
+$110M
5
OA
Orbital ATK, Inc.
OA
+$108M

Sector Composition

Rank Sector Weight
1 Technology 16.72%
2 Industrials 14.06%
3 Consumer Discretionary 12.07%
4 Healthcare 11.22%
5 Financials 8.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABR icon
301
Arbor Realty Trust
ABR
$957M
$4.37M 0.03%
533,178
-122,202
-19% -$996K
CUDA
302
DELISTED
Barracuda Networks, Inc.
CUDA
$4.3M 0.03%
177,443
-1,470,141
-89% -$34.6M
AUPH icon
303
Aurinia Pharmaceuticals
AUPH
$2.07B
$4.27M 0.03%
681,517
+12,171
+2% +$76.7K
LKSD
304
DELISTED
LSC Communications, Inc.
LKSD
$4.13M 0.03%
250,000
-50,795
-17% -$913K
JNCE
305
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$4.08M 0.03%
262,105
+79,683
+44% +$1.13M
CHRW icon
306
C.H. Robinson
CHRW
$17.1B
$4.04M 0.03%
+53,096
New +$3.68M
NGNE icon
307
Neurogene
NGNE
$710M
$4.01M 0.03%
14,128
+252
+2% +$72.3K
LINC icon
308
Lincoln Educational Services
LINC
$1.25B
$4M 0.03%
1,598,872
+813,960
+104% +$2.41M
ASND icon
309
Ascendis Pharma A/S
ASND
$16.4B
$3.99M 0.03%
+110,000
New +$3.16M
CISN
310
CALL
DELISTED
Cision Ltd. Ordinary Share
CISN
$3.91M 0.03%
+300,000
New +$3.5M
SNDX icon
311
Syndax Pharmaceuticals
SNDX
$1.76B
$3.87M 0.03%
330,910
+5,910
+2% +$72.4K
ATYR
312
aTyr Pharma
ATYR
$49.2M
$3.81M 0.03%
53,895
-6,052
-10% -$280K
AGRX
313
DELISTED
Agile Therapeutics
AGRX
$3.75M 0.03%
+420
New +$3.23M
ZVRA icon
314
Zevra Therapeutics
ZVRA
$705M
$3.67M 0.03%
62,021
+1,107
+2% +$59K
HOLX
315
DELISTED
Hologic
HOLX
$3.67M 0.03%
+100,000
New +$4.04M
METC icon
316
Ramaco Resources Class A
METC
$608M
$3.65M 0.03%
568,475
+77,519
+16% +$521K
AXP icon
317
American Express
AXP
$231B
$3.62M 0.03%
40,031
-1,082,290
-96% -$93M
SYNC
318
DELISTED
Synacor, Inc.
SYNC
$3.53M 0.03%
1,307,784
+23,353
+2% +$71.2K
SPWH icon
319
Sportsman's Warehouse
SPWH
$46M
$3.38M 0.03%
750,000
– –
FSTX
320
CALL
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$3.37M 0.03%
50,000
– –
COF icon
321
Capital One
COF
$135B
$3.25M 0.02%
38,434
-69,858
-65% -$5.76M
SIMO icon
322
Silicon Motion
SIMO
$9.07B
$3.23M 0.02%
+67,232
New +$2.98M
RHT
323
DELISTED
Red Hat Inc
RHT
$3.01M 0.02%
27,147
-207,028
-88% -$21.2M
PDCO
324
DELISTED
Patterson Companies, Inc.
PDCO
$2.96M 0.02%
+76,611
New +$3.06M
RDN icon
325
Radian Group
RDN
$4.82B
$2.95M 0.02%
+158,020
New +$2.74M
11 12
13
14 15

Similar funds

Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
MML Investors Services
MML Investors Services Springfield, Massachusetts $36.1B AUM 19.68% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM

Alyeska Investment Group's Q3 2017 Portfolio in Review

As of Q3 2017, Alyeska Investment Group held 602 positions worth $13.4B, up 12% from $12B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Alyeska Investment Group deployed $857M of net new capital in Q3 2017, opening 156 new positions and adding to 172 existing holdings. Its largest new stake was AutoZone: 238,293 shares worth $142M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was AbbVie, an estimated $133M trimmed.

  • Alyeska Investment Group's largest Q3 2017 buy was AutoZone: 238,293 shares worth $142M.
  • Alyeska Investment Group added most to Texas Instruments in Q3 2017, an estimated $175M increase.
  • Alyeska Investment Group's biggest Q3 2017 reduction was AbbVie, cutting an estimated $133M.
  • Alyeska Investment Group fully exited Reynolds American Inc in Q3 2017, selling an estimated $126M.
  • Alyeska Investment Group's ten largest holdings make up 14% of its $13.4B portfolio in Q3 2017.
  • Alyeska Investment Group opened 156 new positions and closed 146 in Q3 2017.
  • Alyeska Investment Group's portfolio value rose 12% quarter-over-quarter to $13.4B.

Based on Alyeska Investment Group's 13F filing for Q3 2017, filed 14 Nov 2017.